BioWorld Asia

Nov. 13, 2002

Partnerships Still Key Strategy For Biotech, Pharma Companies

STUTTGART, Germany - The eighth BIO-Europe 2002 International Partnering Conference drew approximately 1,200 representatives from all sectors of the biotechnology industry to Stuttgart to concentrate on partnering and making deals. (BioWorld International) Read More

New EuropaBio Leader Wants Backing For Biotech Research

Concealment Strategy Of Cancer Virus Could Point To Therapies

GW Releases Positive Phase III Results With Cannabis Drug

Meridian, Biotrin Call Off Merger Talks, Decline To Provide Details

EU Launches Its New Research Program At 3-Day Conference

Biotech Investing Strategies Shift To Deal With Bear Market

Genome Campus At Science Park Finally Granted OK To Go Ahead

Genfit Enters Cardiovascular Deal With Japanese Company

Serono Acquires 92 Percent of Genset, Collaborates with IVAX

Other News to Note

Today's news in brief

BioWorld

BioWorld briefs for July 24, 2026.

4D Nucleome opens new wave of gene regulation research, discovery

BioWorld

After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...

Other news to note for July 22, 2026

BioWorld

Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...

GSK’s newly acquired Jideytro wins FDA nod in NSCLC

BioWorld

About a week after closing its $10.6 billion acquisition of Nuvalent Inc., GSK plc has reaped the first reward, announcing U.S. FDA approval of zidesamtinib in...

Korea targets generics, innovation in drug pricing overhaul

BioWorld

South Korea is moving ahead with its biggest reform of drug review and pricing in more than a decade, reflecting a wider shift across Asian markets to reward...